Huddle Ventures calls itself sector-agnostic. I find that its consumer portfolio is anything but.
Bold Care in sexual wellness. Perfora in oral care. Asaya in skincare for melanin-rich skin. Blue Tokai in specialty coffee. GreenGrahi in insect protein. I'm reading them as consumer beliefs, and they follow a pattern.
Sexual wellness in India is a category the customer will not say out loud. Oral care is a category where the default is a toothpaste tube bought on habit and never reconsidered. Skincare for melanin-rich skin sits directly against a fairness narrative that dominated Indian shelves for thirty years. Coffee is a category where the default is instant. Protein is a category where the default is whey or nothing.
Good films need an enemy of substance. Similarly, Huddle's enemy is the conventional consumer belief, not a competitor.
Huddle's own published thesis on Asaya says this out loud. It talks about the shift away from a skin-lightening obsession, and about 85% of Indians having melanin-rich skin that mainstream formulations were never designed for. They're not arguing about market size. It is a belief-change argument with a market-size argument attached.
What I've inferred is that Huddle backs founders who can fund the cost of re-educating a consumer — because in a category with a wrong default, the first mover pays for the education and the second mover free-rides on it. The fund appears to think being first institutional money into that education is worth the risk that someone else monetises it.
That also explains the founder profile. Neeraj Biyani at Asaya came from Paper Boat, which is the clearest example in Indian consumer of a brand that had to teach a category before it could sell in it.
The structural risk is timing. Belief-change categories are slow, the education spend precedes the revenue, and a ₹150 Cr Fund II writing $500K–1M cheques cannot personally fund that education past the seed round. Huddle needs the next investor to believe the education is working before it has finished.
If my read is right, the archetype I would look for next is a wrong-default category with an existing spender. Specifically, women's fertility and cycle health — where the Indian consumer already spends money, spends it on the wrong things, and has almost no trusted source telling her which product does what.
Whether an educated customer buys it a second time without being educated again.
Which Indian consumer category has the biggest gap between what people spend on and what actually works?